Actinium Pharmaceuticals, Inc. quarterly report, Q2 FY2010

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2010, for Cactus Ventures, Inc. (Note: The input metadata references "Actinium Pharmaceuticals," but the filing text explicitly identifies the registrant as Cactus Ventures, Inc.). The company is a Nevada corporation classified as a shell company and a smaller reporting company. It has no active operations, no employees, and is currently seeking a merger or acquisition target to become a reporting public company.

Key Financial Metrics

MetricSix Months Ended June 30, 2010Six Months Ended June 30, 2009
Revenue$0$0
Net Income (Loss)$19,875$(8,985)
Operating Expenses$10,694$5,989
Cash and Cash Equivalents$174$2,122
Funds in Escrow$34,890$0
Total Assets$35,064$2,122
Total Liabilities$111,481$98,414
Shareholders' Deficit$(76,417)$(96,292)
Working Capital$(1,052)$(27,778)

Debt and Liquidity: The company holds minimal cash ($174) but has $34,890 in escrow funds related to a failed transaction. Total liabilities include $75,365 in notes payable to related parties and $18,404 in accrued interest. The company relies on advances from related parties for working capital.

Material Changes vs. Prior Period

  • Net Income Turnaround: The company reported a net income of $19,875 for the six months ended June 30, 2010, compared to a net loss of $8,985 in the prior year. This reversal was driven primarily by a $35,000 gain on the retention of a deposit from a failed merger attempt, rather than operational success.
  • Expense Increase: Operating expenses increased to $10,694 from $5,989, largely due to higher professional fees ($10,190 vs. $5,445) and accrued legal fees.
  • Asset Composition: Total assets increased significantly due to the $34,890 held in escrow, which became non-refundable after a Letter of Intent expired.
  • Liabilities: Total liabilities increased by approximately $13,000, driven by accrued interest and related party notes.

Outlook, Risks, and Management Commentary

Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. The financial statements do not include adjustments that might be necessary if the company is unable to continue. The company has a negative working capital deficiency and a significant shareholders' deficit.

Business Plan: The company is a "blank check" entity seeking to merge with a private company to provide it with a public listing. There are no specific targets currently under negotiation. Management anticipates expenses of approximately $20,000 for the next 12 months and expects to rely on advances from the president to meet these needs.

Risks:

  • Failure to identify or consummate a business combination.
  • Substantial dilution to existing shareholders upon any future acquisition.
  • Dependence on related party financing.
  • High competition for acquisition targets.

Unusual Items: The $35,000 gain is a non-operating item resulting from the expiration of a non-binding Letter of Intent with a British Virgin Islands company. The funds are currently held in trust pending confirmation of release.

Investor Verification Checklist

  • Shell Status: Verify the company has no revenue-generating operations and is solely seeking a merger target.
  • Escrow Funds: Confirm the status of the $34,890 in escrow; while recorded as an asset, its availability for operations is uncertain pending the release of funds from the trust agent.
  • Related Party Debt: Review the terms of the $75,365 in notes payable to related parties and the $18,404 in accrued interest to assess repayment obligations.
  • Going Concern: Assess the risk of insolvency given the negative working capital and reliance on voluntary advances from the president.
  • Dilution Risk: Understand that any future merger will likely involve a significant issuance of new shares, diluting current ownership.